Heidrun Holland

1.3k total citations
44 papers, 872 citations indexed

About

Heidrun Holland is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Heidrun Holland has authored 44 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Surgery and 13 papers in Genetics. Recurrent topics in Heidrun Holland's work include Glioma Diagnosis and Treatment (9 papers), Genomic variations and chromosomal abnormalities (7 papers) and Cancer Genomics and Diagnostics (6 papers). Heidrun Holland is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Genomic variations and chromosomal abnormalities (7 papers) and Cancer Genomics and Diagnostics (6 papers). Heidrun Holland collaborates with scholars based in Germany, United States and United Kingdom. Heidrun Holland's co-authors include Wolfgang Krupp, Ronald Koschny, Peter Ahnert, Manfred Bauer, Jürgen Meixensberger, Ursula G. Froster, William J. Mack, Andrew F. Ducruet, Michael E. Sughrue and Mark Claire and has published in prestigious journals such as PLoS ONE, Circulation Research and Clinical Cancer Research.

In The Last Decade

Heidrun Holland

43 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidrun Holland Germany 18 304 226 160 135 117 44 872
S Ishimaru Japan 14 522 1.7× 254 1.1× 85 0.5× 77 0.6× 34 0.3× 51 1.1k
Heasoo Koo South Korea 18 316 1.0× 90 0.4× 86 0.5× 44 0.3× 78 0.7× 54 875
James Chan Australia 17 266 0.9× 440 1.9× 87 0.5× 290 2.1× 252 2.2× 32 1.3k
Volkmar Heidecke Germany 22 156 0.5× 507 2.2× 85 0.5× 58 0.4× 181 1.5× 42 1.3k
Cyril Gitiaux France 20 559 1.8× 185 0.8× 328 2.0× 154 1.1× 134 1.1× 84 1.4k
Bin Cai China 16 403 1.3× 143 0.6× 73 0.5× 135 1.0× 31 0.3× 63 1.2k
Ming‐Fu Chiang Taiwan 19 576 1.9× 139 0.6× 93 0.6× 39 0.3× 289 2.5× 36 1.1k
Dalia Waldman Israel 11 560 1.8× 193 0.9× 91 0.6× 77 0.6× 248 2.1× 18 1.1k
Hirokazu Saiwai Japan 16 285 0.9× 153 0.7× 40 0.3× 191 1.4× 108 0.9× 47 968
Arianna Merlini Italy 12 337 1.1× 67 0.3× 218 1.4× 245 1.8× 109 0.9× 12 945

Countries citing papers authored by Heidrun Holland

Since Specialization
Citations

This map shows the geographic impact of Heidrun Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidrun Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidrun Holland more than expected).

Fields of papers citing papers by Heidrun Holland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidrun Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidrun Holland. The network helps show where Heidrun Holland may publish in the future.

Co-authorship network of co-authors of Heidrun Holland

This figure shows the co-authorship network connecting the top 25 collaborators of Heidrun Holland. A scholar is included among the top collaborators of Heidrun Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidrun Holland. Heidrun Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holland, Heidrun, et al.. (2023). SNP array genomic analysis of matched pairs of brain and liver metastases in primary colorectal cancer. Journal of Cancer Research and Clinical Oncology. 149(20). 18173–18183.
2.
Rohani, Leili, Breanna S. Borys, Shiying Liu, et al.. (2020). Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells. Communications Biology. 3(1). 492–492. 19 indexed citations
3.
Kirsten, Holger, Leili Rohani, Peter Ahnert, et al.. (2020). Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue. PLoS ONE. 15(7). e0234986–e0234986. 8 indexed citations
4.
Rohani, Leili, Heidrun Holland, Yahaira Naaldijk, et al.. (2016). Generation of human induced pluripotent stem cells using non-synthetic mRNA. Stem Cell Research. 16(3). 662–672. 30 indexed citations
5.
Zscharnack, Matthias, Gabriela Aust, Frank Peinemann, et al.. (2015). Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP). Journal of Translational Medicine. 13(1). 160–160. 21 indexed citations
6.
Koschny, Ronald, Wolfgang Krupp, Wolf Mueller, et al.. (2014). WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma. Pathology - Research and Practice. 211(2). 109–116. 9 indexed citations
7.
Holland, Heidrun, Holger Kirsten, Peter Ahnert, et al.. (2014). Three gangliogliomas: Results of GTG‐banding, SKY, genome‐wide high resolution SNP‐array, gene expression and review of the literature. Neuropathology. 35(2). 148–157. 3 indexed citations
8.
Koschny, Ronald, Martin R. Sprick, Tobias L. Haas, et al.. (2014). Bortezomib Sensitizes Primary Meningioma Cells to TRAIL-Induced Apoptosis by Enhancing Formation of the Death-Inducing Signaling Complex. Journal of Neuropathology & Experimental Neurology. 73(11). 1034–1046. 15 indexed citations
10.
Holland, Heidrun, Peter Ahnert, Holger Kirsten, et al.. (2013). Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma. Pathology - Research and Practice. 209(9). 541–547. 1 indexed citations
11.
Holland, Heidrun, Peter Ahnert, Holger Kirsten, et al.. (2011). High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas. Cancer Genetics. 204(10). 541–549. 4 indexed citations
12.
Koschny, Ronald, Heidrun Holland, Jaromir Sykora, et al.. (2009). Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. Journal of Neuro-Oncology. 97(2). 171–185. 17 indexed citations
13.
Krupp, Wolfgang, Christoph A. Klein, Ronald Koschny, et al.. (2009). ASSESSMENT OF NEUROPSYCHOLOGICAL PARAMETERS AND QUALITY OF LIFE TO EVALUATE OUTCOME IN PATIENTS WITH SURGICALLY TREATED SUPRATENTORIAL MENINGIOMAS. Neurosurgery. 64(1). 40–47. 45 indexed citations
14.
Krupp, Wolfgang, Heidrun Holland, Ronald Koschny, et al.. (2008). Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array–based mapping and classical cytogenetics. Cancer Genetics and Cytogenetics. 184(2). 87–93. 13 indexed citations
15.
Holland, Heidrun, Ronald Koschny, Wolfgang Krupp, et al.. (2007). Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genetics and Cytogenetics. 173(2). 89–96. 25 indexed citations
16.
Holland, Heidrun, Ronald Koschny, Wolfgang Krupp, et al.. (2007). Cytogenetic and molecular biological characterization of an adult medulloblastoma. Cancer Genetics and Cytogenetics. 178(2). 104–113. 7 indexed citations
17.
Koschny, Ronald, et al.. (2005). Comparative genomic hybridization pattern of non-anaplastic and anaplastic oligodendrogliomas – A meta-analysis. Pathology - Research and Practice. 202(1). 23–30. 10 indexed citations
18.
Holland, T C & Heidrun Holland. (2004). A mathematical model of immunohistochemical preparations, which provides quantitative predictions. Journal of Microscopy. 214(1). 1–6. 4 indexed citations
19.
Kinne, Raimund W., Thomas Liehr, Volkmar Beensen, et al.. (2001). Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Research & Therapy. 3(5). 319–30. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026